Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$193.33 USD
-1.05 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $192.63 -0.70 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-6.06 | -0.76% |
Earnings Summary
For their last quarter, Madrigal Pharmaceuticals (MDGL) reported earnings of -$5.68 per share, missing the Zacks Consensus Estimate of -$5.32 per share. This reflects a negative earnings surprise of 6.77%. Look out for MDGL's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$6.06 per share, reflecting a year-over-year decrease of 43.26%.
Earnings History
Price & Consensus
Zacks News for MDGL
2 Top Biotech Buyout Candidates
MDGL: What are Zacks experts saying now?
Zacks Private Portfolio Services